Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0000874015-22-000093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-05 | 2022-04-01 | IONS | Monia Brett P | CEO, Dir | S - Sale | $37.49 | -355 | 88.7K | -0.4% | -$13.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | S | D | 355 | $37.49 | 88,662 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 10/7/2019. |